These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32014514)

  • 21. Prevalence and Characteristics of HIV-Associated Stroke in a Tertiary Hospital Setting in South Africa.
    Corbett C; Brey N; Pitcher RD; O'Hagan S; Esterhuizen TM; Chow FC; Decloedt EH
    Neurology; 2022 Aug; 99(9):e904-e915. PubMed ID: 36038281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study.
    Smiley CL; Rebeiro PF; Cesar C; Belaunzaran-Zamudio PF; Crabtree-Ramirez B; Padgett D; Gotuzzo E; Cortes CP; Pape J; Veloso VG; McGowan CC; Castilho JL;
    Lancet HIV; 2021 May; 8(5):e266-e273. PubMed ID: 33891877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C.
    So-Armah KA; Lim JK; Lo Re V; Tate JP; Chang CH; Butt AA; Gibert CL; Rimland D; Marconi VC; Goetz MB; Ramachandran V; Brittain E; Long M; Nguyen KL; Rodriguez-Barradas MC; Budoff MJ; Tindle HA; Samet JH; Justice AC; Freiberg MS;
    Prog Cardiovasc Dis; 2020; 63(2):184-191. PubMed ID: 32068085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of community-based antiretroviral therapy initiation models on HIV treatment outcomes: A systematic review and meta-analysis.
    Eshun-Wilson I; Awotiwon AA; Germann A; Amankwaa SA; Ford N; Schwartz S; Baral S; Geng EH
    PLoS Med; 2021 May; 18(5):e1003646. PubMed ID: 34048443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.
    Lawn SD; Meintjes G
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):415-30. PubMed ID: 21504399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes.
    Hsu RK; Fusco JS; Henegar CE; Vannappagari V; Clark A; Brunet L; Lackey PC; Pierone G; Fusco GP
    BMC Infect Dis; 2023 Feb; 23(1):91. PubMed ID: 36782125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a human-centered design approach to adapt a nurse-led cardiovascular disease prevention intervention in HIV clinics.
    Aifah A; Okeke NL; Rentrope CR; Schexnayder J; Bloomfield GS; Bosworth H; Grover K; Hileman CO; Muiruri C; Oakes M; Webel AR; Longenecker CT; Vedanthan R
    Prog Cardiovasc Dis; 2020; 63(2):92-100. PubMed ID: 32092444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial.
    Wirth KE; Gaolathe T; Pretorius Holme M; Mmalane M; Kadima E; Chakalisa U; Manyake K; Matildah Mbikiwa A; Simon SV; Letlhogile R; Mukokomani K; van Widenfelt E; Moyo S; Bennett K; Leidner J; Powis KM; Lebelonyane R; Alwano MG; Jarvis J; Dryden-Peterson SL; Kgathi C; Moore J; Bachanas P; Raizes E; Abrams W; Block L; Sento B; Novitsky V; El-Halabi S; Marukutira T; Mills LA; Sexton C; Pals S; Shapiro RL; Wang R; Lei Q; DeGruttola V; Makhema J; Essex M; Lockman S; Tchetgen Tchetgen EJ
    Lancet HIV; 2020 Jun; 7(6):e422-e433. PubMed ID: 32504575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-related cardiovascular disease: any role for high-density lipoproteins?
    Hudson P; Woudberg NJ; Kamau F; Strijdom H; Frias MA; Lecour S
    Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1221-H1226. PubMed ID: 33006917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes and risk factors for immune recovery and all-cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study.
    Castillo-Rozas G; Tu S; Luz PM; Mejia F; Sierra-Madero J; Rouzier V; Shepherd BE; Cortes CP
    J Int AIDS Soc; 2024 Mar; 27(3):e26214. PubMed ID: 38494667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
    Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing inflammation and its role in comorbidities among persons living with HIV.
    Peterson TE; Baker JV
    Curr Opin Infect Dis; 2019 Feb; 32(1):8-15. PubMed ID: 30461454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV Comorbidities-Pay Attention to Hypertension Amid Changing Guidelines: An Analysis of Texas Medical Monitoring Project Data.
    Hyde JR; Sears SC; Buendia JR; Odem SL; Vaaler ML; Mgbere OO
    Am J Hypertens; 2019 Sep; 32(10):960-967. PubMed ID: 31070706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy.
    Babu H; Ambikan AT; Gabriel EE; Svensson Akusjärvi S; Palaniappan AN; Sundaraj V; Mupanni NR; Sperk M; Cheedarla N; Sridhar R; Tripathy SP; Nowak P; Hanna LE; Neogi U
    Front Immunol; 2019; 10():1965. PubMed ID: 31507593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era.
    Ballocca F; Gili S; D'Ascenzo F; Marra WG; Cannillo M; Calcagno A; Bonora S; Flammer A; Coppola J; Moretti C; Gaita F
    Prog Cardiovasc Dis; 2016; 58(5):565-76. PubMed ID: 26943980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular disease in patients with HIV.
    Ballocca F; D'Ascenzo F; Gili S; Grosso Marra W; Gaita F
    Trends Cardiovasc Med; 2017 Nov; 27(8):558-563. PubMed ID: 28779949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HIV-associated non-AIDS conditions].
    Hasse B; Bernasconi E; Furrer H; Eyer MM; Kovari H
    Ther Umsch; 2014 Aug; 71(8):483-9. PubMed ID: 25093313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era.
    Brickman C; Palefsky JM
    Curr HIV/AIDS Rep; 2015 Dec; 12(4):388-96. PubMed ID: 26475669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and factors associated with hypertension among people living with HIV/AIDS on antiretroviral therapy in Uganda.
    Lubega G; Mayanja B; Lutaakome J; Abaasa A; Thomson R; Lindan C
    Pan Afr Med J; 2021; 38():216. PubMed ID: 34046122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healthcare and treatment experiences among people diagnosed with HIV before and after a province-wide treatment as prevention initiative in British Columbia, Canada.
    Tattersall T; Tam C; Moore D; Wesseling T; Grieve S; Wang L; Bacani N; Montaner JSG; Hogg RS; Barrios R; Salters K
    BMC Public Health; 2022 May; 22(1):1022. PubMed ID: 35597938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.